Cite

HARVARD Citation

    Gyselinck, I. et al. (2022). Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO). ERJ open research. 8 (1), p. . [Online]. 
  
Back to record